tirzepatide glycine vs tirzepatide b12 2ML + + - 30/5/.5mg/ml Strength Tirzepatide (Month 1) 2.5mg |

Over a lifetime, patients treated with tirzepatide were projected to incur costs that were $41,688 lower per patient, while gaining an additional 0.506 QALYs compared with patients receiving semaglutide, thus indicating both longevity and improved quality of life in the model

KFF Health Tracking Poll: The publics views on new prescription weight-loss drugs. October 2024

The lack of anti-atherosclerotic and plaque-stabilizing effects of incretin-based medications might contribute to elevated cardiovascular risk, especially acutely following their discontinuation

The effect intensifies as you escalate doses over the following months

It has been used to control blood sugar in certain people with type 2 diabetes, assist weight loss in some patients, and now treat obstructive sleep apnea in adults with obesity